These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28494157)

  • 1. Side Fenestrations Provide an "Anchor" for a Stable Binding of A1899 to the Pore of TASK-1 Potassium Channels.
    Ramírez D; Arévalo B; Martínez G; Rinné S; Sepúlveda FV; Decher N; González W
    Mol Pharm; 2017 Jul; 14(7):2197-2208. PubMed ID: 28494157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A specific two-pore domain potassium channel blocker defines the structure of the TASK-1 open pore.
    Streit AK; Netter MF; Kempf F; Walecki M; Rinné S; Bollepalli MK; Preisig-Müller R; Renigunta V; Daut J; Baukrowitz T; Sansom MS; Stansfeld PJ; Decher N
    J Biol Chem; 2011 Apr; 286(16):13977-84. PubMed ID: 21362619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the A293 (AVE1231) Binding Site in the Cardiac Two-Pore-Domain Potassium Channel TASK-1: a Common Low Affinity Antiarrhythmic Drug Binding Site.
    Wiedmann F; Kiper AK; Bedoya M; Ratte A; Rinné S; Kraft M; Waibel M; Anad P; Wenzel W; González W; Katus HA; Decher N; Schmidt C
    Cell Physiol Biochem; 2019; 52(5):1223-1235. PubMed ID: 31001961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breathing Stimulant Compounds Inhibit TASK-3 Potassium Channel Function Likely by Binding at a Common Site in the Channel Pore.
    Chokshi RH; Larsen AT; Bhayana B; Cotten JF
    Mol Pharmacol; 2015 Nov; 88(5):926-34. PubMed ID: 26268529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TASK-1 (KCNK3) and TASK-3 (KCNK9) tandem pore potassium channel antagonists stimulate breathing in isoflurane-anesthetized rats.
    Cotten JF
    Anesth Analg; 2013 Apr; 116(4):810-6. PubMed ID: 23460565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidating the Structural Basis of the Intracellular pH Sensing Mechanism of TASK-2 K
    Bustos D; Bedoya M; Ramírez D; Concha G; Zúñiga L; Decher N; Hernández-Rodríguez EW; Sepúlveda FV; Martínez L; González W
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A1899, PK-THPP, ML365, and Doxapram inhibit endogenous TASK channels and excite calcium signaling in carotid body type-1 cells.
    O'Donohoe PB; Huskens N; Turner PJ; Pandit JJ; Buckler KJ
    Physiol Rep; 2018 Sep; 6(19):e13876. PubMed ID: 30284397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular basis for an allosteric inhibition of K
    Rinné S; Kiper AK; Vowinkel KS; Ramírez D; Schewe M; Bedoya M; Aser D; Gensler I; Netter MF; Stansfeld PJ; Baukrowitz T; Gonzalez W; Decher N
    Elife; 2019 Feb; 8():. PubMed ID: 30803485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low pH
    Guarina L; Vandael DH; Carabelli V; Carbone E
    J Physiol; 2017 Apr; 595(8):2587-2609. PubMed ID: 28026020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of lipids on the hydrophobic barrier within the pore of the TWIK-1 K2P channel.
    Aryal P; Abd-Wahab F; Bucci G; Sansom MS; Tucker SJ
    Channels (Austin); 2015; 9(1):44-9. PubMed ID: 25487004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A lower X-gate in TASK channels traps inhibitors within the vestibule.
    Rödström KEJ; Kiper AK; Zhang W; Rinné S; Pike ACW; Goldstein M; Conrad LJ; Delbeck M; Hahn MG; Meier H; Platzk M; Quigley A; Speedman D; Shrestha L; Mukhopadhyay SMM; Burgess-Brown NA; Tucker SJ; Müller T; Decher N; Carpenter EP
    Nature; 2020 Jun; 582(7812):443-447. PubMed ID: 32499642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lateral Fenestrations in K(+)-Channels Explored Using Molecular Dynamics Simulations.
    Jorgensen C; Darré L; Oakes V; Torella R; Pryde D; Domene C
    Mol Pharm; 2016 Jul; 13(7):2263-73. PubMed ID: 27173896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Small-Molecule Compound Selectively Activates K2P Channel TASK-3 by Acting at Two Distant Clusters of Residues.
    Tian F; Qiu Y; Lan X; Li M; Yang H; Gao Z
    Mol Pharmacol; 2019 Jul; 96(1):26-35. PubMed ID: 31015283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K2P channel gating mechanisms revealed by structures of TREK-2 and a complex with Prozac.
    Dong YY; Pike AC; Mackenzie A; McClenaghan C; Aryal P; Dong L; Quigley A; Grieben M; Goubin S; Mukhopadhyay S; Ruda GF; Clausen MV; Cao L; Brennan PE; Burgess-Brown NA; Sansom MS; Tucker SJ; Carpenter EP
    Science; 2015 Mar; 347(6227):1256-9. PubMed ID: 25766236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TASK-1 and TASK-3 may form heterodimers in human atrial cardiomyocytes.
    Rinné S; Kiper AK; Schlichthörl G; Dittmann S; Netter MF; Limberg SH; Silbernagel N; Zuzarte M; Moosdorf R; Wulf H; Schulze-Bahr E; Rolfes C; Decher N
    J Mol Cell Cardiol; 2015 Apr; 81():71-80. PubMed ID: 25655935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Targets for Old Drugs: Cardiac Glycosides Inhibit Atrial-Specific K
    Schmidt C; Wiedmann F; Gaubatz AR; Ratte A; Katus HA; Thomas D
    J Pharmacol Exp Ther; 2018 Jun; 365(3):614-623. PubMed ID: 29643254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure/Activity Analysis of TASK-3 Channel Antagonists Based on a 5,6,7,8 tetrahydropyrido[4,3-d]pyrimidine.
    Ramírez D; Bedoya M; Kiper AK; Rinné S; Morales-Navarro S; Hernández-Rodríguez EW; Sepúlveda FV; Decher N; González W
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Pharmacology of K
    Decher N; Rinné S; Bedoya M; Gonzalez W; Kiper AK
    Cell Physiol Biochem; 2021 Mar; 55(S3):87-107. PubMed ID: 33667333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional mutagenesis screens reveal the 'cap structure' formation in disulfide-bridge free TASK channels.
    Goldstein M; Rinné S; Kiper AK; Ramírez D; Netter MF; Bustos D; Ortiz-Bonnin B; González W; Decher N
    Sci Rep; 2016 Jan; 6():19492. PubMed ID: 26794006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K
    Lolicato M; Arrigoni C; Mori T; Sekioka Y; Bryant C; Clark KA; Minor DL
    Nature; 2017 Jul; 547(7663):364-368. PubMed ID: 28693035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.